| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5642618 | Oral Oncology | 2017 | 7 Pages |
Abstract
Rosiglitazone exerted a protective action on normal tissues in radiation-induced mucositis. Moreover, it showed antineoplastic properties on head-neck carcinoma xenograft model and selective protection of normal tissues. Thus, PPAR gamma agonists should be further investigated as radioprotective agents in head and neck cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Mangoni Monica, Sottili Mariangela, Gerini Chiara, Desideri Isacco, Bastida Cinzia, Pallotta Stefania, Castiglione Francesca, Bonomo Pierluigi, Meattini Icro, Greto Daniela, Olmetto Emanuela, Terziani Francesca, Becherini Carlotta, Delli Paoli Camilla,